The next generation of disruptive companies built from
ground-breaking science

Mr. Antalich is the former Chief Executive Officer of ICC Labs Inc. (TSXV), a pioneering Canadian company that became the first publicly traded entity in the world to sell cannabis to a federal government, effectively bridging the gap between the stigma surrounding controlled substances and regulatory bodies. Through strategic foresight, determination, commitment, responsibility, teamwork, and passion, he led ICC Labs to its successful sale to Aurora (TSX) in November 2018, a milestone $300 million transaction that positioned Aurora as a dominant force in the industry. An accomplished entrepreneur and investor, he possesses a keen commercial instinct and a visionary approach to business growth, with extensive expertise spanning the medtech, foodtech, and pharmaceutical industries. With a strong focus on innovation, biotechnology, biomedical sciences, medtech, and clinical research, Mr. Antalich currently leads Biomind Labs Inc., a Canadian publicly traded life sciences company specializing in mental health and tailored drug delivery systems targeting specific therapeutic indications. He is also at the helm of EvokAI Creative Labs Inc., another Canadian publicly traded company dedicated to developing transformational and innovative technologies for the modern healthcare sector, particularly in the area of integrated AI deep learning for brain health. In addition to these roles, he serves as the Chairman of Eternal, focusing on high-impact areas such as alternative proteins, space exploration technology, and bio-based materials, leading the transition towards a more sustainable and ethical global ecosystem, further extending his influence in the realms of biotechnology and healthcare innovation.